Andean Precious Metals (CVE:APM) Stock Price Down 10.4% – Should You Sell?

Shares of Andean Precious Metals Corp. (CVE:APMGet Free Report) traded down 10.4% on Tuesday . The company traded as low as C$1.12 and last traded at C$1.12. 535,049 shares changed hands during mid-day trading, an increase of 177% from the average session volume of 193,465 shares. The stock had previously closed at C$1.25.

Analyst Ratings Changes

Separately, Desjardins raised Andean Precious Metals to a “moderate buy” rating in a report on Thursday, October 31st.

Read Our Latest Analysis on APM

Andean Precious Metals Trading Down 10.4 %

The firm has a market capitalization of C$167.28 million, a PE ratio of 2.95 and a beta of 1.22. The firm’s fifty day moving average price is C$1.41 and its 200 day moving average price is C$1.25.

Insider Activity at Andean Precious Metals

In other news, insider 2176423 Ontario Ltd. acquired 84,400 shares of the company’s stock in a transaction dated Tuesday, October 8th. The shares were acquired at an average price of C$1.51 per share, with a total value of C$127,359.60. 69.37% of the stock is currently owned by insiders.

About Andean Precious Metals

(Get Free Report)

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.

Featured Articles

Receive News & Ratings for Andean Precious Metals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andean Precious Metals and related companies with MarketBeat.com's FREE daily email newsletter.